Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults

Clinical trial NCT00426270 · COMPLETED

Trial details

NCT number: NCT00426270
Sponsor: Octapharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenic Purpura

Start date: 2006-06-01
Primary completion: 2008-09-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.